Cizzle Biotechnology Holdings plc
Cizzle Biotechnology PLCAliasCizzle バイオテクノロジー ホールディングス plcAlias
§01
Basic information
- Head office
- C/O Ampa Holdings LLP, Level 19, The Shard, 32 London Bridge Street, London SE1 9SG
- Chief executive
- Allan Syms
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2007-03-01
- End date
§02
Websites
§03
Business
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| CFO Solutions Ltd | ||||||||
| BBI | ||||||||
| Moffitt Cancer Center, USA | ||||||||
| University of York | ||||||||
| Finance Yorkshire | ||||||||
| Viking Members | ||||||||
| White Rose Technology Seedcorn Fund | ||||||||
| Yorkshire Cancer Research |
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Capital
Customer
Supplier
Partnership
Bank / shareholder
Drag to move · click to open
§06
History
First prospective clinical studies commence in real-world setting
Cizzle Biotechnology Founded by Prof Dawn Coverley, and spun out from the University of York
Seed funding secured from Yorkshire Cancer Research, White Rose Technology Seedcorn Fund, Finance Yorkshire, and Viking Members.
Landmark publication by Higgins G, et al showing CIZ1B capable of detecting early-stage lung cancer
Coverley et al publish major commercial advance by showing CIZ1B can be measured using a high-throughput, hospital-friendly ELISA format to detect lung cancer.
Licensing and royalty agreement for China market. New monoclonal antibodies developed to enable optimisation of commercial test
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain：Yes
UPDATED2026-10-09 07:47 · Model: gpt-oss-20b(99)